Evidence map›Paper›PMID 42418586›Full record

ArticleScience advances2026

Moonlighting role of meiotic SYCP1 in breast cancer: A chromatin-bound regulator of DNA repair, transcription, and drug resistance.

Louise C Brennan, Oleg V Grinchuk, Miguel Pachon-Penalba, Ieng F Sou, Conor J Fawcett, Claudia G Nogueira, Megan Guthrie, Andrew D Bates, Megan Hine, Amanda Thomaz and 4 more

Abstract read
In one paragraph

Article in Science advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Louise C BrennanInstitute of Systems, Molecular and Integrative Biology, University of Liverpool, Crown Street, Liverpool, UK.ORCID 0000-0003-0324-2665
Oleg V GrinchukChromatin Dynamics and Disease Epigenetics Lab, Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), 61 Biopolis Drive, Proteos, Singapore 138673, Republic of Singapore.ORCID 0000-0002-0746-2705
Miguel Pachon-PenalbaCentre for Cell Biology, Institute of Cell Biology, University of Edinburgh, Michael Swann Building, Max Born Crescent, Edinburgh, UK.
Ieng F SouInstitute of Systems, Molecular and Integrative Biology, University of Liverpool, Crown Street, Liverpool, UK.
Conor J FawcettInstitute of Systems, Molecular and Integrative Biology, University of Liverpool, Crown Street, Liverpool, UK.ORCID 0009-0008-0057-983X
Claudia G NogueiraInstitute of Medical Biology, Polish Academy of Sciences, Tylna 3A, Lodz, Poland.ORCID 0000-0002-4230-0808
Megan GuthrieInstitute of Systems, Molecular and Integrative Biology, University of Liverpool, Crown Street, Liverpool, UK.ORCID 0009-0007-1456-4818
Andrew D BatesInstitute of Systems, Molecular and Integrative Biology, University of Liverpool, Crown Street, Liverpool, UK.ORCID 0009-0008-8633-4322
Megan HineDivision of Biomedical and Life Sciences, Faculty of Health and Medicine, Lancaster University, Lancaster, UK.ORCID 0009-0002-4710-4862
Amanda ThomazDivision of Biomedical and Life Sciences, Faculty of Health and Medicine, Lancaster University, Lancaster, UK.ORCID 0000-0002-8671-5124
Andew B FieldingDivision of Biomedical and Life Sciences, Faculty of Health and Medicine, Lancaster University, Lancaster, UK.ORCID 0000-0002-3170-9966
Owen R DaviesCentre for Cell Biology, Institute of Cell Biology, University of Edinburgh, Michael Swann Building, Max Born Crescent, Edinburgh, UK.ORCID 0000-0002-3806-5403
Wee-Wei TeeChromatin Dynamics and Disease Epigenetics Lab, Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), 61 Biopolis Drive, Proteos, Singapore 138673, Republic of Singapore.ORCID 0000-0003-4952-6567
Urszula L McClurgInstitute of Systems, Molecular and Integrative Biology, University of Liverpool, Crown Street, Liverpool, UK.ORCID 0000-0003-2631-4174

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Maintenance of genome integrity is essential for cellular homeostasis, and its perturbation leads to tumorigenesis. Here, we uncover an unanticipated somatic role for the synaptonemal complex protein SYCP1, previously regarded as strictly meiosis specific, in a broad spectrum of human cancers including breast cancer. Through integrative genomic, proteomic, and functional analyses, we demonstrate that SYCP1 is aberrantly reexpressed in tumor cells, where it actively promotes DNA damage repair, cell cycle progression, and malignant growth. SYCP1 binds chromatin at regulatory elements and directly controls transcriptional programs governing genome maintenance, including key effectors such as

Indexed as

Breast NeoplasmsChromatinDNA RepairDrug Resistance, NeoplasmMeiosisTranscription, GeneticCell Line, TumorCell ProliferationCisplatinFemaleGene Expression Regulation, NeoplasticHumansChromatinCisplatin

Identifiers

PMID42418586
PMCPMC13344282

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.